CVS Health posted impressive Q1 2025 results with jumps in revenue, net income, and sales, yet it still decided to rain on ...

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

Patrons will be directed to the 24-hour 2000 Pennsylvania Ave. location, which is located inside Western Market.

The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

In the quarter, CVS Health CVS delivered 7% revenue and 71% adjusted EPS growth, showing progress in Medicare Advantage after ...

Eli Lilly CEO David Ricks is confident that weight loss med Zepbound is gaining market share at the expense of Wegovy, even as its rival strikes deals with CVS and Hims & Hers pharmacies.

CVS Health Corporation ( NYSE: CVS) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial ...

Ohio State researchers found that Americans in nearly half of all counties live in what’s called a pharmacy desert, meaning ...

JACKSON - Mississippi Attorney General Lynn Fitch has taken action against popular pharmacy programs that say they aim to ...

Mississippi Attorney General Lynn Fitch announced Thursday that her office has secured a temporary restraining order against GoodRx, Inc.; GoodRx Holdings, Inc.; MS CVS Pharmacy, LLC; and Inside Rx, ...

Attorney General Lynn Fitch sought and secured a temporary restraining order (TRO) against GoodRx, Inc.; GoodRx Holdings, Inc ...